NCAM1 and gastric cancer: The results indicate no significant differences in most of the analyzed parameters between younger and older GC patients, except for CD3-CD56+dimTLR-9+ and CD3-CD56+brightTLR-9+, which were statistically significantly higher in GC patients ≤ 50 (Figure 6D,H).